Protein microarray analysis for detection of serum anti-helicobacter pylori antibodies after eradication therapy: A clinical follow-up

Hepato-Gastroenterology

Volumn 62, Issue 138, 2015, Pages 503-506

  Cui, Meihua ^a   Wei, Hong ^a   Mu, Fanghong ^a   Yi, Guoxing ^a   Fu, Yi ^a   Yue, Lin ^a  

^a AEROSPACE CENTER HOSPITAL   (China)

Author keywords

Eradication therapy; Follow up study; Helicobacter pylori; Protein microassay; Virulence factor

Indexed keywords

AMOXICILLIN; BACTERIAL ENZYME; BACTERIUM ANTIBODY; BISMUTH CITRATE; CAGA PROTEIN; CHAPERONIN 60; ESOMEPRAZOLE; METRONIDAZOLE; UREA C 13; UREASE; VACUOLATING TOXIN; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; VACA PROTEIN, HELICOBACTER PYLORI;

ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL CLEARANCE; BREATH ANALYSIS; CHRONIC GASTRITIS; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER PYLORI; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN MICROARRAY; ADULT; AGED; BLOOD; CHRONIC DISEASE; DRUG EFFECTS; DUODENAL ULCER; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HUMAN; IMMUNOLOGY; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; REMISSION; STOMACH ULCER; TIME; TREATMENT OUTCOME; VIRULENCE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BREATH TESTS; CHRONIC DISEASE; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTON PUMP INHIBITORS; REMISSION INDUCTION; STOMACH ULCER; TIME FACTORS; TREATMENT OUTCOME; UREASE; VIRULENCE; VIRULENCE FACTORS;

EID: 84928566447     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge14624     Document Type: Article

References (16)

1. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis 2008; 40:619-626.
2. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht IV / Florence Consensus Report. Gut 2012; 61:646-664.
3. Wang J, Xu L, Shi R., et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion 2011; 83:253-260.
4. Fukase K, Kato M, Kikuchi S., et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397.
5. Kim MS, Kim N, Kim S.E., et al. Long-term Follow-up Helicobacter Pylori Reinfection Rate and Its Associated Factors in Korea. Helicobacter 2013; 18:135-142.
6. Cui MH, Zhu HX, Liu L, et al Clinical value of protein chip in diagnosis of Helicobacter pylori infections. Chin J Nosocomiol 2013; 23:1216-1217.
7. Koumi A, Filippidis T, Leontara V., et al. Detection of Helicobacter pylori: A faster urease test can save resources. World J Gastroenterol 2011; 17:349-353.
8. Marie MA. Relationship between Helicobacter pylori virulence genes and clinical outcomes in Saudi patients. J Korean Med Sci 2012; 27:190-193.
9. Lin CS, He PJ, Tsai N.M., et al. A potential role for Helicobacter pylori heat shock protein 60 in gastric tumorigenesis. Biochem Biophys Res Commun 2010; 392:183-189.
10. Kaakoush NO, Asencio C, Megraud F., et al. A redox basis for metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother 2009; 53:1884-1891.
11. Sugimoto M, Yamaoka Y. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy. Arch Immunol Ther Exp (Warsz) 2009; 57:45-56.
12. Zhao JJ, Wang JB, Yang L, et al Influence of Helicobacter pylori genotype on triple eradication therapy. J Gastroenterol Hepatol 2007; 22:2251-2255.
13. Cui MH, Zhang XL, Zhang X.Y., et al. Detection and distribution of Helicobacter pylori antibodies by protein chip in gastroduodenal disease. Journal of Chinese Physician 2012; 14:865-867.
14. Russo F, Berloco P, Cuomo R., et al. Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: a study from southern Italy. Aliment Pharmacol Ther 2003; 17:421-428.
15. Ribardo DA, Bingham-Ramos LK, Hendrixson DR. Functional analysis of the RdxA and RdxB nitroreductases of Campylobacter jejuni reveals that mutations in rdxA confer metronidazole resistance. J Bacteriol 2010; 192:1890-1901.
16. Lee JH, Kim N, Chung J.I., et al. Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea. Helicobacter 2008; 3:288-294.